dipyridamole has been researched along with sildenafil citrate in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, H; Ishibashi, K; Ishihara, H; Kabasawa, Y; Kakiki, M; Kodama, K; Matsukura, M; Miyazaki, K; Nishino, M; Ozaki, H; Takase, Y; Watanabe, N | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bankala, R; Doss, HM; Kapavarapu, RK; Kulkarni, P; Kumar, JS; Mathew, JE; Medishetti, R; Mudgal, J; Pal, M; Parsa, KVL; Ramarao, EVVS; Rasool, M; Shenoy, GG; Sunke, R; Thirupataiah, B | 1 |
| Berzetei-Gurske, I; Bivalacqua, TJ; Champion, HC; Doherty, PC; Greenwood-Van Meerveld, B; Hellstrom, WJ; Kadowitz, PJ | 1 |
| Billah, MM; Egan, RW; Myers, JG; Stamford, A; Wang, P; Wu, P | 1 |
| Patole, SK; Travadi, JN | 1 |
| Cogolludo, Al; Lodi, F; Losada, B; Lugnier, C; Moreno, L; Moro, M; Pérez-Vizcaíno, F; Tamargo, J; Villamor, E | 1 |
| Nosengo, N | 1 |
| Botigelli, RC; Castro, FC; Del Collado, M; Fernandes, H; Leal, CLV; Schwarz, KL; Zaffalon, FG | 1 |
1 review(s) available for dipyridamole and sildenafil citrate
| Article | Year |
|---|---|
Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review.
Topics: Dipyridamole; Endothelium-Dependent Relaxing Factors; Humans; Infant, Newborn; Nitric Oxide; Pentoxifylline; Persistent Fetal Circulation Syndrome; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Purinones; Sildenafil Citrate; Sulfones | 2003 |
8 other study(ies) available for dipyridamole and sildenafil citrate
| Article | Year |
|---|---|
4-(3-Chloro-4-methoxybenzyl)aminophthalazines: synthesis and inhibitory activity toward phosphodiesterase 5.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antihypertensive Agents; Biological Availability; Blood Pressure; Coronary Vessels; Cyclic Nucleotide Phosphodiesterases, Type 5; Dinoprost; Hypertension, Pulmonary; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Phthalazines; Piperidines; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Swine; Vasodilator Agents | 2000 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
InCl
Topics: Animals; Arthritis; Cyclic Nucleotide Phosphodiesterases, Type 4; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Indium; Indoles; Molecular Structure; Multiple Sclerosis; Oligodendrocyte-Myelin Glycoprotein; Phosphodiesterase 4 Inhibitors; Quinoxalines; Rats; Structure-Activity Relationship; Zebrafish; Zebrafish Proteins | 2019 |
Direct effects of selective type 5 phosphodiesterase inhibitors alone or with other vasodilators on the erectile response in cats.
Topics: Alprostadil; Animals; Cats; Dipyridamole; Dose-Response Relationship, Drug; Male; Nitroprusside; Penile Erection; Phosphodiesterase Inhibitors; Piperazines; Purines; Purinones; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2001 |
Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; Chromatography; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; Dogs; Humans; Isoenzymes; Kinetics; Male; Muscle, Smooth; Penis; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Purinones; Rabbits; Sildenafil Citrate; Species Specificity; Sulfones | 2001 |
Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Animals, Newborn; Blotting, Western; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dipyridamole; In Vitro Techniques; Male; Nitric Oxide; Nitroprusside; Phosphodiesterase Inhibitors; Piperazines; Pulmonary Artery; Purines; Purinones; Sildenafil Citrate; Sulfones; Swine; Vasodilation; Vasodilator Agents | 2004 |
Can you teach old drugs new tricks?
Topics: Animals; Azoles; Bipolar Disorder; Carbazoles; Clinical Trials, Phase II as Topic; Dipyridamole; Drug Approval; Drug Evaluation, Preclinical; Drug Industry; Drug Repositioning; Drugs, Generic; Dry Eye Syndromes; Epilepsy; Humans; Isoindoles; Mice; Multiple Sclerosis; Neoplasms; Off-Label Use; Organoselenium Compounds; Patents as Topic; Sildenafil Citrate; Zidovudine | 2016 |
Influence of nitric oxide and phosphodiesterases during in vitro maturation of bovine oocytes on meiotic resumption and embryo production.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blastocyst; Cattle; Cyclic AMP; Cyclic GMP; Dipyridamole; Female; Fertilization in Vitro; In Vitro Oocyte Maturation Techniques; Male; Meiosis; Nitric Oxide; Nitric Oxide Donors; Oocytes; Phosphodiesterase Inhibitors; Quinolones; S-Nitroso-N-Acetylpenicillamine; Sildenafil Citrate | 2017 |